GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I agree that NASDAQ would be great, but when you look at the minimum requirements, such as the minimum bid price, then I think it's unlikely.
Amen to that RN1MLT, let's see what happens.
First reaction to it - All in line with expectations, bonus is that all the sectors are growing at 20% and now allograft division can also pull in revenue from this year.
Interesting to see change of advisor also pairing with the fact that we were Q4 EBDTA positive, so by Q3 2023 we will be 1 FY EBDTA positive, is this the indication of where we will be heading, a Nasdaq listing? It makes perfect sense to me - Its healthcare (defensive sector- flavour for next 18 months), EBDTA positive (only place IIs want to invest now) and bonus is its growing (so it will come out well from this slow growth phase in US)!! To me, nothing more perfect for NASDAQ listing later this year. Raise serious cash to fuel serious growth.
Solid update, will be interesting how the market reacts . My broker is showing Bid 0.65 Ask 0.70 so no change. GLA in 2023 for all holders.
Great news. We shouldn't expect much information in a trading update the detail will come in the final results statement. The change of NOMAD is interesting though. LH&K Mafuta
Agreed. Either this is a solid company with a long term growth opportunity, or it's a buy out option. Either way the sp should put on a solid performance over the next week or so.
And if it does become a buy out (and I hope it doesn't!) TRX suddenly got more expensive!
and.. with cash so robust and credit facility increase (demonstrating confidence in the business)) no question of a rights issue which so often on aim destroys LTHs
Yes so unpredictable but hopefully direction of travel with all three divisions picking up, new distribution agreements and expanded capacity this share will finally begin to see significant sp increases but as you say AIM can be so perverse ....
Yes it's a bit short on detail isn't it. Wonder if there will be an investor meet coming up?
It's been a long time coming for TRX has this. Given the contrary nature of AIM I wouldn't be surprised if it drops on opening!
Thanks! And pleasingly wrong on cash in hand
Well done on the total sales figure izstar, two points to you!
Brilliant news - and no mention of a takeover either, which I was dreading.
"We are delighted to have achieved an adjusted EBITDA profit for the fourth quarter of 2022"
I'll take that!
About Finncap:
'We advise ambitious growth companies, access capital and promote their stories across public and private markets. We are solution agnostic, providing the best advice for each business requirement to fuel faster growth, build value and we are trusted to deliver.'
Now time to read the other RNS
is out on lse - $24.5m
Usually there is a bit of a leak on rns releases. Never really understood why or who. Think though the update will come at 07.00 hrs so there is an hour to either wave your arms in the air ofr cut your throat!!
This is just a waiting game....
As expected had a reply from my email with absolutely no helpful information whatsoever, guess we just cross our fingers and wait for this potential volcano to erupt !
They are doing well and have a great CEO and CFO team - eyes will be on the margins and costs ...like everywhere else
need to know when the China deal is likely to begin and what size inventory will they be looking at creating , initially
I have emailed the investor relations email , not expecting much back to be fair but if i get anything ill post on here
Yes I know - so frustrating - worth waiting for though - if projections at half year were accurate together with new contracts we should see reasonable numbers and more importantly, increasingly positive momentum going forward - professional management and great products - what's not to like
Where is that blessed update?!
My understanding is if it was traded for LESS than the mid-way point it's a sell, if it's over it's a buy. All trades are someone buying and someone selling, so it's the execution price in relation to the midpoint that determines what it's classed as on here.
Clearly those people don't know what's coming ! ;P
@Banditkong: somebody else was selling ;-)
my two additional purchases today are listed as sells not buys ? can someone shed some light on this for me ? cheers